NYSE:AMPE Ampio Pharmaceuticals (AMPE) Stock Price, News & Analysis $2.05 -0.31 (-13.14%) (As of 12/29/2023 ET) Add Compare Share Share Today's Range$2.00▼$2.3650-Day Range$1.78▼$5.8552-Week Range$1.73▼$8.30Volume144,083 shsAverage Volume176,274 shsMarket Capitalization$1.71 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media About Ampio Pharmaceuticals Stock (NYSE:AMPE)Ampio Pharmaceuticals, Inc., a biopharmaceutical company, develops therapies for the treatment of osteoarthritis-related pain. It focuses on the preclinical development of AR-300, a novel proprietary, small molecule formulation for the treatment of osteoarthritis of the knee. The company is headquartered in Englewood, Colorado.Read More AMPE Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart AMPE Stock News HeadlinesDecember 30, 2023 | americanbankingnews.comAmpio Pharmaceuticals (NYSE:AMPE) Receives New Coverage from Analysts at StockNews.comDecember 28, 2023 | seekingalpha.comSociedad Quimica Y Minera de Chile, Altice USA, Cingulate among premarket gainers' packDecember 31, 2023 | Behind the Markets (Ad)New Year's Sale: Get 12 Months of Stock Picks for $9.00Gear up for what's happening in the stock market in 2024. Our friends at Behind the Markets are offering an opportunity that is simply too good to pass up - 12-months of their best stock ideas for just $9.00. Don't sleep on this. December 23, 2023 | americanbankingnews.comAmpio Pharmaceuticals (NYSE:AMPE) Now Covered by Analysts at StockNews.comDecember 1, 2023 | msn.comWhat's Going On With Ampio Pharmaceuticals Stock?December 1, 2023 | msn.comRedhill Biopharma, Ampio Pharmaceuticals among healthcare moversNovember 30, 2023 | benzinga.comThinking about buying stock in Aditxt Inc, Ampio Pharmaceuticals, TOP SHIPS, Mullen Automotive, or Oatly GroupOctober 5, 2023 | finance.yahoo.comAmpio Selects Ascendia Pharmaceuticals, Inc. to Provide CDMO Services to Support Clinical Development of OA-201December 31, 2023 | MarketBeat Internal (Ad)MarketBeat All Access New Year's Sale - Just $1.00Access our premier research platform that includes MarketBeat Daily Premium, portfolio monitoring tools, stock screeners, research tools, a real-time news feed, email and SMS alerts, the MarketBeat Idea Engine, proprietary brokerage rankings, extended data export tools and much more. Save 75% Your 2024 Subscription. Just $1.00 for the first 30 days.October 4, 2023 | finance.yahoo.comPresenting on the Emerging Growth Conference 63 Day 2 on October 5 Register NowSeptember 26, 2023 | finance.yahoo.comAmpio Pharmaceuticals to Present at the Emerging Growth ConferenceSeptember 7, 2023 | thestreet.comAmpio Pharmaceuticals (AMPE) Stock Tanks Today after Treatment Fails To Reach Primary EndpointAugust 31, 2023 | seekingalpha.comAmpio Pharmaceuticals announces 20-to-1 reverse stock splitAugust 31, 2023 | markets.businessinsider.comAmpio Pharmaceuticals Board Approves Reverse Stock Split - Quick FactsAugust 31, 2023 | finance.yahoo.comAmpio Pharmaceuticals Announces Reverse Stock SplitAugust 3, 2023 | benzinga.comThinking about buying stock in Wavedancer, Urogen Pharma, Ampio Pharmaceuticals, Innoviz Technologies, or Rigetti Computing?June 22, 2023 | msn.com3 Biotech Stocks to Buy With Explosive Upside PotentialJune 3, 2023 | finance.yahoo.comAMPE - Ampio Pharmaceuticals, Inc.May 26, 2023 | finance.yahoo.comAmpio Pharmaceuticals Announces Series D Preferred Stock Dividend to its Holders of Common StockApril 18, 2023 | seekingalpha.comAmpio stock jumps ~20% after CEO letter on drug program, reorganizationApril 3, 2023 | thestreet.comAmpio Too Busy to Tell Investors Results of Eye Drug StudyFebruary 9, 2023 | thestreet.comWhy Ampio Pharmaceuticals (AMPE) Stock Is Plummeting TodayFebruary 7, 2023 | wsj.comSHAREHOLDER ALERT: Rigrodsky Law, P.A. Is Investigating Ampio Pharmaceuticals, Inc.December 27, 2022 | finance.yahoo.comAmpio Pharmaceuticals Regains Compliance with NYSE American Continued Listing StandardsNovember 17, 2022 | finance.yahoo.comAmpio Pharmaceuticals Announces NYSE American Removal of Trading SuspensionNovember 8, 2022 | finance.yahoo.comAmpio Pharmaceuticals Announces Fifteen-to-One Reverse Stock SplitOctober 16, 2022 | stockhouse.comMONDAY DEADLINE NOTICE: The Schall Law Firm Encourages Investors in Ampio Pharmaceuticals, Inc. with Losses of $100,000 to Contact the FirmSee More Headlines Receive AMPE Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Ampio Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings11/14/2023Today12/31/2023Fiscal Year End12/31/2023Next Earnings (Estimated)3/25/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNYSE Industry Pharmaceutical preparations Sub-IndustryN/A SectorMedical Current SymbolNYSE:AMPE CUSIPN/A CIK1411906 Webampiopharma.com Phone720-437-6500Fax720-437-6501Employees5Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)($12.13) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-16,340,000.00 Net MarginsN/A Pretax MarginN/A Return on Equity-111.36% Return on Assets-85.59% Debt Debt-to-Equity RatioN/A Current Ratio3.37 Quick Ratio3.37 Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book Value$15.62 per share Price / Book0.13Miscellaneous Outstanding Shares830,000Free Float805,000Market Cap$1.70 million OptionableOptionable Beta2.36 20 Stocks to Sell NowMarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.Get This Free Report Key ExecutivesMr. Michael A. Martino (Age 66)CEO & Director Comp: $548.14kDr. David Bar-Or M.D. (Age 74)Founder & Chairman of Scientific Advisory Board Comp: $145.6kMr. Daniel G. Stokely CPA (Age 59)CFO, Corporate Secretary & Treasurer Comp: $346.73kApril RamirezClinical Trial ManagerKey CompetitorsInMed PharmaceuticalsNASDAQ:INMPhio PharmaceuticalsNASDAQ:PHIOPaxMedicaNASDAQ:PXMDScopus BioPharmaNASDAQ:SCPSDermata TherapeuticsNASDAQ:DRMAView All CompetitorsInsidersJ Kevin BuchiBought 1,250 shares on 6/8/2023Total: $7,500.00 ($6.00/share)Michael A MartinoBought 3,844 shares on 5/24/2023Total: $22,295.20 ($5.80/share)David R StevensBought 2,500 shares on 5/11/2023Total: $11,000.00 ($4.40/share)View All Insider Transactions AMPE Stock Analysis - Frequently Asked Questions How have AMPE shares performed in 2023? Ampio Pharmaceuticals' stock was trading at $4.5040 at the beginning of the year. Since then, AMPE shares have decreased by 54.5% and is now trading at $2.05. View the best growth stocks for 2023 here. When is Ampio Pharmaceuticals' next earnings date? The company is scheduled to release its next quarterly earnings announcement on Monday, March 25th 2024. View our AMPE earnings forecast. How were Ampio Pharmaceuticals' earnings last quarter? Ampio Pharmaceuticals, Inc. (NYSE:AMPE) issued its earnings results on Tuesday, November, 14th. The company reported ($1.53) earnings per share (EPS) for the quarter. When did Ampio Pharmaceuticals' stock split? Ampio Pharmaceuticals shares reverse split on the morning of Tuesday, September 12th 2023. The 1-20 reverse split was announced on Thursday, August 31st 2023. The number of shares owned by shareholders was adjusted after the closing bell on Monday, September 11th 2023. An investor that had 100 shares of stock prior to the reverse split would have 5 shares after the split. What other stocks do shareholders of Ampio Pharmaceuticals own? Based on aggregate information from My MarketBeat watchlists, some companies that other Ampio Pharmaceuticals investors own include Tesla (TSLA), Agenus (AGEN) and American Airlines Group (AAL). How do I buy shares of Ampio Pharmaceuticals? Shares of AMPE stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NYSE:AMPE) was last updated on 12/31/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Ampio Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.